Resultados globales: 2 registros encontrados en 0.02 segundos.
Artículos, Encontrados 2 registros
Artículos Encontrados 2 registros  
1.
14 p, 1007.9 KB A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT) : initial results from an international prospective study / Bancroft, Elizabeth K (Royal Marsden NHS Foundation Trust, London) ; Page, Elizabeth C (Institute of Cancer Research, London) ; Brook, Mark N (Institute of Cancer Research, London) ; Thomas, Sarah (Royal Marsden NHS Foundation Trust, London) ; Taylor, Natalie (Royal Marsden NHS Foundation Trust, London) ; Pope, Jennifer (Institute of Cancer Research, London) ; McHugh, Jana (Institute of Cancer Research, London) ; Jones, Ann-Britt (Institute of Cancer Research, London) ; Karlsson, Questa (Institute of Cancer Research, London) ; Merson, Susan (Institute of Cancer Research, London) ; Ong, Kai Ren (Birmingham Women's Hospital) ; Hoffman, Jonathan (Birmingham Women's Hospital) ; Huber, Camilla (Birmingham Women's Hospital) ; Maehle, Lovise (Oslo University Hospital (Oslo, Noruega)) ; Grindedal, Eli Marie (Oslo University Hospital (Oslo, Noruega)) ; Stormorken, Astrid (Oslo University Hospital (Oslo, Noruega)) ; Evans, D Gareth (University of Mancheste) ; Rothwell, Jeanette (University of Manchester) ; Lalloo, Fiona (University of Manchester) ; Brady, Angela F (London North West University Healthcare NHS Trust, Harrow) ; Bartlett, Marion (London North West University Healthcare NHS Trust, Harrow) ; Snape, Katie (St George's Hospital, Tooting, London) ; Hanson, Helen (St George's Hospital, Tooting, London) ; James, Paul (The University of Melbourne) ; McKinley, Joanne (Parkville Familial Cancer Centre, Melbourne) ; Mascarenhas, Lyon (Parkville Familial Cancer Centre, Melbourne) ; Syngal, Sapna (Brigham and Women's Hospital (Boston, Estats Units d'Amèrica)) ; Ukaegbu, Chinedu (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Side, Lucy (Wessex Princess Anne Hospital, Southampton) ; Thomas, Tessy (Princess Anne Hospital, Southampton) ; Barwell, Julian (University Hospitals Leicester, Leicester) ; Teixeira, Manuel R (Porto University, Porto) ; Izatt, Louise (Guy's and St Thomas' NHS Foundation Trust, London) ; Suri, Mohnish (Nottingham University Hospitals NHS Trust, Nottingham) ; Macrae, Finlay A (Royal Melbourne Hospital (Melbourne, Austràlia)) ; Poplawski, Nicola (University of Adelaide, Adelaide) ; Chen-Shtoyerman, Rakefet (Ariel University, Ariel) ; Ahmed, Munaza (Institute of Child Health, London) ; Musgrave, Hannah (Leeds Teaching Hospitals NHS Trust, Leeds) ; Nicolai, Nicola (Fondazione IRCCS Istituto Nazionale dei Tumori, Milano) ; Greenhalgh, Lynn (Clinical Genetics Service, Liverpool Women's Hospital, Liverpool) ; Brewer, Carole (Royal Devon & Exeter Hospital (Exeter, Regne Unit)) ; Pachter, Nicholas (University of Western Australia, Perth) ; Spigelman, Allan D (St Vincent's Hospital, Sydney) ; Azzabi, Ashraf (Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne) ; Helfand, Brian T (NorthShore University HealthSystem, Evanston) ; Halliday, Dorothy (Oxford University Hospitals NHS Trust) ; Buys, Saundra (University of Utah, Salt Lake City) ; Ramon y Cajal, Teresa (Institut d'Investigació Biomèdica Sant Pau) ; Donaldson, Alan (St Michael's Hospital, Bristol) ; Cooney, Kathleen A (Duke Cancer Institute and Duke University School of Medicine, Durham) ; Harris, Marion (Monash University, Clayton) ; McGrath, John (University of Exeter Medical School, Exeter) ; Davidson, Rosemarie (Queen Elizabeth University Hospital, Glasgow) ; Taylor, Amy (Cambridge University Hospitals NHS Trust, Cambridge) ; Cooke, Peter (New Cross Hospital, Wolverhampton, UK) ; Myhill, Kathryn (Royal Marsden NHS Foundation Trust, London) ; Hogben, Matthew (Royal Marsden NHS Foundation Trust, London) ; Aaronson, Neil K (The Netherlands Cancer Institute, Amsterdam) ; Ardern-Jones, Audrey (Royal Marsden NHS Foundation Trust, London) ; Bangma, Chris H (Erasmus Cancer Institute, Rotterdam) ; Castro, Elena (Spanish National Cancer Research Center, Madrid) ; Dearnaley, David (The Institute of Cancer Research, Sutton) ; Dias, Alexander (Instituto Nacional de Cancer Jose de Alencar Gomes da Silva INCA, Rio de Janeiro) ; Dudderidge, Tim (University Hospital Southampton) ; Eccles, Diana M (University of Southampton, Southampton) ; Green, Kate (University of Manchester, Manchester) ; Eyfjord, Jorunn (University of Iceland, Reykjavik) ; Falconer, Alison (Imperial College Healthcare NHS Trust, London) ; Foster, Christopher S (HCA Pathology Laboratories, London) ; Gronberg, Henrik (University Hospital of Umeå) ; Hamdy, Freddie C (University of Oxford) ; Johannsson, Oskar (Landspitali - the National University Hospital of Iceland, Reykjavik) ; Khoo, Vincent (The Institute of Cancer Research, Sutton, Surrey) ; Lilja, Hans (Department of Laboratory Medicine, Memorial Sloan-Kettering Cancer Center, New York) ; Lindeman, Geoffrey J (The Walter and Eliza Hall Institute of Medical Research, Parkville) ; Lubinski, Jan (Pomeranian Medical University in Szczecin) ; Axcrona, Karol (Department of Urology, Akershus University Hospital, Lørenskog) ; Mikropoulos, Christos (Royal Surrey County Hospital, Guildford) ; Mitra, Anita V (University College London Hospitals NHS Foundation Trust, London) ; Moynihan, Clare (Institute of Cancer Research, London) ; Ni Raghallaigh, Holly (Institute of Cancer Research, London) ; Rennert, Gad (CHS National Cancer Control Center, Haifa) ; Collier, Rebecca (Nottingham University Hospitals NHS Trust) ; Offman, Judith (King's College London) ; Kote-Jarai, Zsofia (Institute of Cancer Research) ; Eeles, Rosalind A (Royal Marsden NHS Foundation Trust, London) ; Universitat Autònoma de Barcelona
Lynch syndrome is a rare familial cancer syndrome caused by pathogenic variants in the mismatch repair genes MLH1, MSH2, MSH6, or PMS2, that cause predisposition to various cancers, predominantly colorectal and endometrial cancer. [...]
2021 - 10.1016/S1470-2045(21)00522-2
The Lancet. Oncology, Vol. 22 (november 2021) , p. 1618-1631  
2.
14 p, 2.9 MB Exploring the link between MORF4L1 and risk of breast cancer / Martrat, Griselda (Institut d'Investigació Biomèdica de Bellvitge) ; Maxwell, Christopher A. (Institut d'Investigació Biomèdica de Bellvitge) ; Tominaga, Emiko (The University of Texas Health Science Center at San Antonio) ; Porta de la Riva, Montserrat (Institut d'Investigació Biomèdica de Bellvitge) ; Bonifaci, Núria (Institut d'Investigació Biomèdica de Bellvitge) ; Gomez-Baldo, Laia (Institut d'Investigació Biomèdica de Bellvitge) ; Bogliolo, Massimo (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Lazaro, Conxi (Institut d'Investigació Biomèdica de Bellvitge) ; Blanco Guillermo, Ignacio (Institut d'Investigació Biomèdica de Bellvitge) ; Brunet, Joan (Hospital Universitari de Girona Doctor Josep Trueta) ; Aguilar, Helena (Institut d'Investigació Biomèdica de Bellvitge) ; Fernández-Rodríguez, Juana (Hospital Universitari de Girona Doctor Josep Trueta) ; Seal, Sheila (Institute of Cancer Research (Sutton, Regne Unit)) ; Renwick, Anthony (Institute of Cancer Research (Sutton, Regne Unit)) ; Rahman, Nazneen (Institute of Cancer Research (Sutton, Regne Unit)) ; Kühl, Julia (University of Würzburg. Department of Human Genetics (Würzburg, Alemanya)) ; Neveling, Kornelia (University of Würzburg. Department of Human Genetics (Würzburg, Alemanya)) ; Schindler, Detlev (University of Würzburg. Department of Human Genetics (Würzburg, Alemanya)) ; Ramírez de Haro, Ma. José (María José) (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Castellà, María (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Hernández Viedma, Gonzalo (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Easton, Douglas F. (University of Cambridge. Department of Public Health and Primary Care) ; Peock, Susan (University of Cambridge. Department of Public Health and Primary Care) ; Cook, Margaret (University of Cambridge. Department of Public Health and Primary Care) ; Oliver, Clare T. (University of Cambridge. Department of Public Health and Primary Care) ; Frost, Debra (University of Cambridge. Department of Public Health and Primary Care) ; Platte, Radka (University of Cambridge. Department of Oncology) ; Evans, D. Gareth (Central Manchester University Hospitals NHS Foundation Trust (Manchester, Regne Unit)) ; Lalloo, Fiona (Central Manchester University Hospitals NHS Foundation Trust (Manchester, Regne Unit)) ; Eeles, Rosalind (The Institute of Cancer Research (Sutton, Regne Unit)) ; Izatt, Louise (Guy's and St Thomas NHS Foundation Trust (Londres, Regne Unit)) ; Chu, Carol (Yorkshire Regional Genetics Service (Leeds, Regne Unit)) ; Davids, Rosemarie (Ferguson-Smith Centre for Clinical Genetics (Glasgow, Regne Unit)) ; Ong, Kai-Ren (Birmingham Women's Hospital Healthcare NHS Trust (Birmingham, Regne Unit)) ; Cook, Jackie (Sheffield Children's Hospital (Sheffield, Regne Unit)) ; Douglas, Fiona (Newcastle Upon Tyne Hospitals NHS Trust (Newcastle, Regne Unit)) ; Hodgson, Shirley (University of London. St George's Hospital) ; Brewer, Carole (Royal Devon & Exeter Hospital (Exeter, Regne Unit)) ; Morrison, Patrick J. (Northern Ireland Regional Genetics Centre (Belfast, Regne Unit)) ; Porteous, Mary (South East of Scotland Regional Genetics Service (Edimburg, Regne Unit)) ; Peterlongo, Paolo (Fondazione IRCCS Istituto Nazionale Tumori (Milà, Itàlia)) ; Manoukian, Siranoush (Fondazione IRCCS INT (Milà, Itàlia)) ; Peissel, Bernard (Fondazione IRCCS INT (Milà, Itàlia)) ; Zaffaroni, Daniela (Fondazione IRCCS INT (Milà, Itàlia)) ; Roversi, Gaia (Fondazione IRCCS INT (Milà, Itàlia)) ; Barile, Monica (Istituto Europeo di Oncologia (Milà, Itàlia)) ; Viel, Alessandra (Centro di Riferimento Oncologico (Aviano, Itàlia)) ; Pasini, Barbara (University of Turin. Department of Genetics, Biology and Biochemistry (Torí, Itàlia)) ; Ottini, Laura (Sapienza University of Rome. Department of Molecular Medicine) ; Putignano, Anna Laura (University of Florence. Department of Clinical Physiopathology (Florència, Itàlia)) ; Savarese, Antonella (Regina Elena Cancer Institute (Roma, Itàlia)) ; Bernard, Loris (IEO. Department of Experimental Oncology (Milà, Itàlia)) ; Radice, Paolo (Fondazione IRCCS Istituto Nazionale Tumori (Milà, Itàlia)) ; Healey, Sue (Queensland Institute of Medical Research. Division of Genetics and Population Health (Brisbane, Austràlia)) ; Spurdle, Amanda (Queensland Institute of Medical Research. Division of Genetics and Population Health (Brisbane, Austràlia)) ; Chen, Xiaoqing (Queensland Institute of Medical Research. Division of Genetics and Population Health (Brisbane, Austràlia)) ; Beesley, Jonathan (Queensland Institute of Medical Research. Division of Genetics and Population Health (Brisbane, Austràlia)) ; Rookus, Matti A. (The Netherlands Cancer Institute. Department of Epidemiology (Amsterdam, Països Baixos)) ; Verhoef, Senno (The Netherlands Cancer Institute. Family Cancer Clinic (Amsterdam, Països Baixos)) ; Tilanus-Linthorst, Madeleine A. (Erasmus MC-Daniel den Hoed Cancer Center (Rotterdam, Països Baixos)) ; Vreeswijk, Maaike P. (Leiden University Medical Center. Center for Human and Clinical Genetics (Leiden, Països Baixos)) ; Asperen, Christi J. (Leiden University Medical Center. Center for Human and Clinical Genetics (Leiden, Països Baixos)) ; Bodmer, Danielle (Radboud University Nijmegen Medical Center. Department of Human Genetics (Nijmegen, Països Baixos)) ; Ausems, Margreet G. E. M. (University Medical Center Utrecht. Department of Medical Genetics (Utrecht, Països Baixos)) ; van Os, Theo A. (Academic Medical Center, Department of Clinical Genetics (Amsterdam, Països Baixos)) ; Blok, Marinus J. (University Hospital Maastricht. Department of Clinical Genetics (Maastricht, Països Baixos)) ; Meijers-Heijboer, Hanne E. J. (VU Medical Center. Department of Clinical Genetics (Amsterdam, Països Baixos)) ; Hogervorst, Frans B. L. (The Netherlands Cancer Institute. Family Cancer Clinic (Amsterdam, Països Baixos)) ; Goldgar, David E. (University of Utah School of Medicine. Department of Dermatology (Salt Lake City, Estats Units d'Amèrica)) ; Buys, Saundra (Huntsman Cancer Institute (Salt Lake City, Estats Units d'Amèrica)) ; John, Esther M. (Cancer Prevention Institute of California (Fremont, Estats Units d'Amèrica)) ; Miron, Alexander (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica). Department of Cancer Biology) ; Southey, Melissa (The University of Melbourne. Melbourne School of Population Health (Austràlia)) ; Daly, Mary B. (Fox Chase Cancer Center. Division of Population Science (Philadelphia, Estats Units d'Amèrica)) ; Harbst, Katja (Lund University. Department of Oncology (Lund, Suècia)) ; Borg, Åke (Lund University. Department of Oncology (Lund, Suècia)) ; Rantala, Johanna (Karolinska University Hospital) ; Barbany-Bustinza, Gisela (Karolinska University Hospital) ; Ehrencrona, Hans (Uppsala University. Departament of Genetics and Pathology (Uppsala, Suècia)) ; Stenmark-Askmalm, Marie (Hälsouniversitetet Universitetssjukhuset. Department of Oncology (Linköping, Suècia)) ; Kaufman, Bella (Chaim Sheba Medical Center. The Institute of Oncology (Ramat Gan, Israel)) ; Laitman, Yael (Chaim Sheba Medical Center (Israel)) ; Milgrom, Roni (Chaim Sheba Medical Center (Israel)) ; Friedman, Eitan (Chaim Sheba Medical Center (Israel)) ; Domchek, Susan M. (University of Pennsylvania School of Medicine. Abramson Cancer Center (Philadelphia, Estats Units d'Amèrica)) ; Nathanson, Katherine L. (University of Pennsylvania School of Medicine. Abramson Cancer Center (Philadelphia, Estats Units d'Amèrica)) ; Rebbeck, Timothy R. (University of Pennsylvania School of Medicine. Abramson Cancer Center (Philadelphia, Estats Units d'Amèrica)) ; Johannsson, Oskar Thor (20A Landspitali-LSH v/Hringbraut. Department of Oncology (Reykjavik, Islàndia)) ; Couch, Fergus J. (Mayo Clinic. Department of Laboratory Medicine and Pathology (Rochester, Estats Units d'Amèrica)) ; Wang, Xianshu (Mayo Clinic. Department of Laboratory Medicine and Pathology (Rochester, Estats Units d'Amèrica)) ; Fredericksen, Zachary (Mayo Clinic. Department of Health Sciences Research (Rochester, Estats Units d'Amèrica)) ; Cuadras, Daniel (Institut d'Investigació Biomèdica de Bellvitge) ; Morros, Rosa (South East of Scotland Regional Genetics Service, Western General Hospital (Edimburg, Regne Unit)) ; Pientka, Friederike K. (University of Lübeck. Center for Structural and Cell Biology in Medicine (Lübeck, Alemanya)) ; Depping, Reinhard (University of Lübeck. Center for Structural and Cell Biology in Medicine (Lübeck, Alemanya)) ; Caldés, Trinidad (Hospital Clínico San Carlos (Madrid)) ; Osorio, Ana (Centro Nacional de Investigaciones Oncológicas) ; Benítez, Javier (Centro Nacional de Investigaciones Oncológicas) ; Bueren, Juan (Centro de Investigaciones Energéticas, Medioambientales, y Tecnológicas (Madrid, Espanya)) ; Heikkinen, Tuomas (Helsinki University Central Hospital. Department of Obstetrics and Gynecology (Helsinki, Finlàndia)) ; Surrallés i Calonge, Jordi (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Pujana, Miguel Angel (Institut d'Investigació Biomèdica de Bellvitge) ; Tominaga, Kaoru (The University of Texas Health Science Center at San Antonio) ; Cerón, Julián (Institut d'Investigació Biomèdica de Bellvitge) ; Antoniou, Antonis C. (University of Cambridge. Department of Public Health and Primary Care) ; Fert Ferrer, Sandra (Hôtel Dieu Centre Hospitalier (Chambéry, França)) ; Collonge-Rame, Marie-Agnès (Centre Hospitalier Universitaire de Besançon (Besançon, França)) ; Mortemousque, Isabelle (Centre Hospitalier Universitaire Bretonneau (Tours, França)) ; McGuffog, Lesley (University of Cambridge. Department of Public Health and Primary Care) ; Chenevix-Trench, Georgia (Queensland Institute of Medical Research (Brisbane, Austràlia)) ; Pereira-Smith, Olivia M. (The University of Texas Health Science Center at San Antonio) ; Nevanlinna, Heli (Helsinki University Central Hospital. Department of Obstetrics and Gynecology (Helsinki, Finlàndia)) ; Hamann, Ute (Deutsches Krebsforschungszentrum (Heidelberg, Alemanya)) ; Torres, Diana (Pontificia Universidad Javeriana. Instituto de Genética Humana (Bogota, Colòmbia)) ; Caligo, Maria Adelaide (University Hospital of Pisa (Pisa, Itàlia)) ; Godwin, Andrew K. (University of Kansas Medical Center. Department of Pathology and Laboratory MedicineCenter (Kansas, Estats Units d'Amèrica)) ; Imyanitov, Evgeny N. (N.N. Petrov Institute of Oncology. Laboratory of Molecular Oncology (Sant Petersburg, Rússia)) ; Janavicius, Ramunas (Vilnius University Hospital Santariskiu Clinics. Hematology, Oncology and Transfusion Medicine Center (Vilnius, Lituània)) ; Sinilnikova, Olga M. (Centre Hospitalier Universitaire de Lyon. Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents (Lyon, França)) ; Stoppa-Lyonnet, Dominique (Institut Curie) ; Mazoyer, Sylvie (Université Lyon 1. Cancer Research Center of Lyon (Lyon, França)) ; Verny-Pierre, Carole (Université Lyon 1. Cancer Research Center of Lyon (Lyon, França)) ; Castera, Laurent (Institut Curie) ; de Pauw, Antoine (Institut Curie) ; Bignon, Yves-Jean (Université de Clermont-Ferrand. Département d'Oncogénétique (Clermont-Ferrand, França)) ; Uhrhammer, Nancy (Université de Clermont-Ferrand. Département d'Oncogénétique (Clermont-Ferrand, França)) ; Peyrat, Jean-Philippe (Centre Oscar Lambret. Laboratoire d'Oncologie Moléculaire Humaine (Lille, França)) ; Vennin, Philippe (Centre Oscar Lambret. Consultation d'Oncogénétique (Lille, França)) ; The Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab) ; The Netherlands Cancer Institute. Hereditary Breast and Ovarian Cancer Group (HEBON) ; University of Utah School of Medicine. Breast Cancer Family Registry (Salt Lake City, Estats Units d'Amèrica) ; Lund University. Swedish Breast Cancer Study (Lund, Suècia) ; Fédération Nationale des Centres de Lutte Contre le Cancer. Groupe Génétique et Cancer (Lyon, França)
Introduction: Proteins encoded by Fanconi anemia (FA) and/or breast cancer (BrCa) susceptibility genes cooperate in a common DNA damage repair signaling pathway. To gain deeper insight into this pathway and its influence on cancer risk, we searched for novel components through protein physical interaction screens. [...]
2011 - 10.1186/bcr2862
Breast cancer research, Vol. 13, Núm. R40 (4 2011) -14  

Vea también: autores con nombres similares
1 Eeles, R.A.
4 Eeles, Ros
1 Eeles, Rosalind A
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.